DeepMed Research

VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults

Completed

Conditions: Influenza, Human
Influenza Type B
Influenza A H3N2
Influenza A H1N1
Influenza
Vaccine Reaction
Influenza A

Interventions: Biological: Influenza Vaccine Recipients

First Posted Date: 2018-11-16

Last Posted Date: 2019-08-05

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 10

Registration Number: NCT03743688

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Disorders of the Acute Phase Response Following Trauma and Invasive Surgery

Not Applicable

Conditions: Acute Phase Response

Interventions: Procedure: Blood draw (venipuncture or fingerstick)

First Posted Date: 2018-11-14

Last Posted Date: 2024-03-08

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 320

Registration Number: NCT03741023

Locations: 🇺🇸
Vanderbilt Univeristy Medical Center, Nashville, Tennessee, United States

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

Active, not recruiting

Conditions: Post Intensive Care Syndrome

First Posted Date: 2018-11-13

Last Posted Date: 2024-08-12

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 200

Registration Number: NCT03738774

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

and more 2 locations

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1

Phase 4

Terminated

Conditions: Hypertension

Interventions: Drug: Valsartan
Drug: LCZ696
Drug: Bradykinin
Drug: Substance P
Drug: BNP
Drug: Sitagliptin

First Posted Date: 2018-11-13

Last Posted Date: 2025-03-11

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 4

Registration Number: NCT03738878

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

Completed

Conditions: Cognitive Decline

Interventions: Drug: 540,000 IU vitamin D3
Drug: Placebo

First Posted Date: 2018-11-07

Last Posted Date: 2024-10-21

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 95

Registration Number: NCT03733418

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 4 locations

Change in MUNIX in Patients With CMT1A Undergoing a Home Ankle Strengthening Program Versus Standard of Care

Not Applicable

Completed

Conditions: Charcot-Marie-Tooth Disease

Interventions: Other: Standard of Care
Other: Home Ankle Strengthing Program

First Posted Date: 2018-10-23

Last Posted Date: 2019-12-20

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 19

Registration Number: NCT03715283

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease

Terminated

Conditions: Renal Cell Carcinoma
Hypertension
Melanoma
Cancer

Interventions: Diagnostic Test: Ambulatory Blood Pressure Measurement

First Posted Date: 2018-10-17

Last Posted Date: 2024-01-12

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 2

Registration Number: NCT03709771

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Interventions to Improve Specialty Medication Adherence

Not Applicable

Completed

Conditions: Nonadherence, Medication
Adherence, Medication

Interventions: Behavioral: Pharmacist-Driven Intervention

First Posted Date: 2018-10-17

Last Posted Date: 2023-12-01

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 438

Registration Number: NCT03709277

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup

Phase 4

Terminated

Conditions: Croup
Asthma

Interventions: Drug: Dexamethasone IV for PO
Drug: Dexamethasone crushed tablets

First Posted Date: 2018-10-15

Last Posted Date: 2021-11-08

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 40

Registration Number: NCT03705273

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Utility of PCD Diagnostics to Improve Clinical Care

Not Applicable

Recruiting

Conditions: Primary Ciliary Dyskinesia

Interventions: Other: nNO testing

First Posted Date: 2018-10-12

Last Posted Date: 2025-01-06

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 200

Registration Number: NCT03704207

Locations: 🇺🇸
Vanderbilt Children's hospital, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy